Stereospecific Absorption and Degradation of Cephalexin
Overview
Pharmacy
Authors
Affiliations
Stereospecific absorption and degradation of two stereoisomers about the alpha-amino group at the 7-position of cephalexin (CEX) have been investigated in the rat intestine. The L-isomer (L-CEX) was not found to be present either in serum or urine after oral administration, but the D-isomer (D-CEX) was well absorbed. In contrast to the saturable uptake of D-CEX (Kt = 10.54 +/- 1.73 mM, pH = 6.0) by the in-vitro everted intestinal sac, no appreciable uptake of L-CEX was observed. However, L-CEX competitively inhibited the uptake of D-CEX by the in-vitro everted intestine and the inhibitory constant (Ki) of L-CEX was determined to be 0.67 +/- 0.09 mM. L-CEX was rapidly degraded in-vitro in the intestinal tissue homogenate, serum and urine, while there was no appreciable degradation of D-CEX. Analysis of the major metabolite of L-CEX by high-performance liquid chromatography identified it as 7-aminodeacetoxycephalosporanic acid (7-ADCA). Furthermore, 7-ADCA was detected in serum after oral administration of L-CEX, indicating significant absorption of L-CEX as well as D-CEX. The results obtained suggest that both L- and D-CEX can be absorbed through the intestinal brush-border membrane via the same mechanism, most likely through the dipeptide transport system, and that the affinity of L-CEX to the carrier system is higher than that of D-CEX.(ABSTRACT TRUNCATED AT 250 WORDS)
Targeted prodrug design to optimize drug delivery.
Han H, Amidon G AAPS PharmSci. 2001; 2(1):E6.
PMID: 11741222 PMC: 2751001. DOI: 10.1208/ps020106.
Padoin C, Tod M, Perret G, Petitjean O Antimicrob Agents Chemother. 1998; 42(6):1463-9.
PMID: 9624495 PMC: 105623. DOI: 10.1128/AAC.42.6.1463.
Stereoselective disposition of sulbenicillin in humans.
Itoh T, Watanabe N, Ishida M, Tsuda Y, Koyano S, Tsunoi T Antimicrob Agents Chemother. 1998; 42(2):325-31.
PMID: 9527780 PMC: 105408. DOI: 10.1128/AAC.42.2.325.
Bioequivalence of chiral drugs. Stereospecific versus non-stereospecific methods.
Mehvar R, Jamali F Clin Pharmacokinet. 1997; 33(2):122-41.
PMID: 9260035 DOI: 10.2165/00003088-199733020-00004.
SNYDER N, Tabas L, Berry D, Duckworth D, Spry D, Dantzig A Antimicrob Agents Chemother. 1997; 41(8):1649-57.
PMID: 9257735 PMC: 163979. DOI: 10.1128/AAC.41.8.1649.